Abstract
Gastric cancer is a malignancy with a strong global distribution, being more common in Asian countries like Japan and South Korea. As such, treatment algorithms differ significantly between the Eastern countries and Western. According to the Japanese Gastric Cancer Guidelines, neoadjuvant therapy is not utilized, even for advanced stage cancers (1).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have